RenRe lines up next $750m towards Validus buy; could wield $4.65bn
Global reinsurer RenaissanceRe has lined up $750 million from bond investors as it continues to line up financing for its agreed-to deal to purchase Validus Re from AIG.
RenRe struck terms for the $750 million issue of 10-year senior unsecured notes with a fixed-rate 5.75% coupon, management said of an ongoing process.
It's the latest step towards the nearly $3 billion purchase of AIG's reinsurance operations which has already seen the firm raise a net $1.352 billion from a neighbourhood 15% capital increase.
RenRe is slated to pay AIG $2.74 billion in cash and $250 million in new equity for the array of reinsurance operations, chiefly Validus Re, exclusive of 95% of reserve development, plus the ILS manager AlphaCat and renewal rights to the treaty reinsurance book at Talbots.
The new debt will be pari passu to all other existing unsubordinated debt, but would be forced to early redemption should the Validus Re deal fall through.
For the debt deal underway, Morgan Stanley, Barclays, HSBC, Wells Fargo Securities, and BofA Securities served as joint book-running managers.
RenRe had additionally put $1.55 billion on stand-by bridge financing at Morgan Stanley.
The total accumulated cash pile (treating new equity as pure liquidity), could now extend to $4.65 billion.
RenRe has indicated it hopes to remain both heavily capitalised and highly liquid through the lead-up to the Q4 transaction. Company officials have suggested that organic growth plans remain full steam ahead for this year.
Indirectly, AIG will also help finance the deal. As part of the sales agreement, AIG has agreed to put up to $500 million into the RenRe third-party capital vehicles that RenRe will be using to back reinsurance liabilities from Validus.
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze